11h data presented at the ISAM World Congress

11h in the news
Written By Tithi

An accepted abstract highlighted the program’s potential in substance use disorders.

Tithi
Previous

Federal grants support PDE4 programs in neurological disease
Next

Goldenrod Therapeutics Announces Abstract Accepted for Presentation at The International Society of Addiction Medicine’s (ISAM) 2022 World Congress Meeting